WARNING: Market Shock Imminent

Join us on September 29 at 4 p.m. ET at the Market Shock 2022 event to find out what’s coming and how to profit.

Thu, September 29 at 4:00PM ET
 
 
 
 

10 Best “Strong Buy” Stocks — STMP NSP IPXL and more

This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.

Stamps.com (STMP) has risen 49.4% since the first of the year. Stamps.com is an Internet-based company that allows customers to send mail. For more information, get Portfolio Grader’s complete analysis of STMP stock.

The price of Insperity, Inc. (NSP) has seen a 49.9% boost since the first of the year. Insperity provides personnel management that encompasses a range of services, including benefits and payroll administration, health and workers’ compensation insurance programs and personnel records management. For more information, get Portfolio Grader’s complete analysis of NSP stock.

Shares of Impax Laboratories, Inc. (IPXL) have risen 50.5% since January 1. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.

Since January 1, the price of Ellie Mae, Inc. (ELLI) has grown 58.3%. Ellie Mae provides business automation software for the mortgage industry in the United States. For more information, get Portfolio Grader’s complete analysis of ELLI stock.

Since the first of the year, shares of Teekay Tankers Ltd. Class A (TNK) have soared 59.6%. Teekay Tankers owns oil tankers and transports crude oil. For more information, get Portfolio Grader’s complete analysis of TNK stock.

The price of China Biologic Products, Inc. (CBPO) is up 62.6% since the first of the year. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

ABIOMED, Inc. (ABMD) has risen 73.6% since the first of the year. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

Since January 1, Skechers U.S.A., Inc. Class A (SKX) has shot up 95.9%. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.

Since January 1, Ebix, Inc. (EBIX) has jumped 102.4%. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.

Since the first of the year, the price of Chimera Investment Corporation (CIM) has swelled 326.5%. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock has a trailing PE Ratio of 5.40. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/06/10-best-strong-buy-stocks-stmp-nsp-ipxl-and-more-stmp-nsp-ipxl/.

©2022 InvestorPlace Media, LLC